Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients. 2000

N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan.

Bronchoconstrictor cysteinyl leukotrienes (LT) and thromboxane (TX) A2 have been implicated in the pathogenesis of asthma. Determination of urinary leukotriene E4 (LTE4) and 11-dehydro-TXB2 levels are often used to assess cysteinyl LT and TXA2 production in humans. To define the potential role in the pathogenesis of asthma, we investigated the urinary LTE4 and 11-dehydro-TXB2 levels. LTE4 and 11-dehydro-TXB2 levels were determined using liquid chromatography/tandem mass spectrometry (LC/MS) and gas chromatography/mass spectrometry (GC/MS), respectively. Urinary LTE4 levels in asthmatic patients (192 +/- 122 pg/mg creatinine, n = 14) were significantly higher (P < 0.005) than those in healthy volunteers (55 +/- 16 pg/mg creatinine, n = 13), but no significant difference in 11-dehydro-TXB2 levels was observed. A significant inverse correlation (r = -0.821, P < 0.005) was found between urinary LTE4 levels and the forced expiratory volume in 1 s (FEV1) but no significant correlation was observed between urinary 11-dehydro-TXB2 levels and FEV1. The present findings suggest that cysteinyl LTs play a more important role in the pathogenesis of asthma than TXA2.

UI MeSH Term Description Entries
D008297 Male Males
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
May 1994, The European respiratory journal,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
July 1996, Prostaglandins,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
February 1992, Nihon rinsho. Japanese journal of clinical medicine,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
December 1992, Allergy,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
May 1993, Prostaglandins,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
January 1995, Contraception,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
November 1986, Prostaglandins,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
January 2006, American journal of veterinary research,
N Suzuki, and T Hishinuma, and F Abe, and K Omata, and S Ito, and M Sugiyama, and M Mizugaki
January 1986, Prostaglandins, leukotrienes, and medicine,
Copied contents to your clipboard!